EXTENDED INDUCTION IN THE TRUE NORTH OPEN-LABEL EXTENSION STUDY: CLINICAL OUTCOMES OF ∼2 YEARS OF OZANIMOD TREATMENT

被引：0
|
作者：
Rubin, David T.
Colombel, Jean Frederic
Chiorean, Michael V.
Ghosh, Subrata
Jain, Anjali
Lawlor, Garrett
Osterman, Mark T.
Wu, Hsiuanlin
Canavan, James B.
Vermeire, Severine
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1736
引用
收藏
页码：S1102 / S1102
页数：1
相关论文
共 50 条
  • [31] Humoral Immune Responses to SARS-CoV-2 Vaccines in an Ozanimod Open-Label Extension Study
    Caldera, Freddy
    Maddux, Rachel
    Ungaro, Ryan
    Kaur, Amandeep
    Brown, Elizabeth
    Hu, Sarah
    Sheffield, James K.
    Silva, Diego
    Harris, Sarah
    Cree, Bruce A. C.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S527 - S528
  • [32] SAFETY OF LONG-TERM OZANIMOD TREATMENT FOR UP TO 4 YEARS BY AGE GROUP IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: AN INTERIM ANALYSIS OF THE TRUE NORTH OPEN-LABEL EXTENSION
    Siegel, Corey A.
    Rubin, David T.
    Long, Millie D.
    Danese, Silvio
    Cross, Raymond K.
    Armuzzi, Alessandro
    Dignass, Axel
    Kobayashi, Taku
    Faye, Adam S.
    Lama, Sonie
    Charles, Lorna
    Cetin, Volkan
    Petersen, AnnKatrin
    Wu, Hsiuanlin
    Wang, Dong
    Jain, Anjali
    Sabino, Joao
    GASTROENTEROLOGY, 2024, 166 (05) : S805 - S806
  • [33] RECAPTURE OF RESPONSE WITH OZANIMOD IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO WITHDREW THERAPY: DATA FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
    Afzali, Anita
    Chiorean, Michael V.
    Lawlor, Garrett
    Osterman, Mark T.
    Eren, Devrim
    Memaj, Arteid
    Panaccione, Remo
    Ghosh, Subrata
    GASTROENTEROLOGY, 2022, 162 (07) : S229 - S229
  • [34] Delayed Response to Ozanimod in Patients with Moderate vs Severe Endoscopic Disease: 4-Year Interim Analysis of the True North Open-Label Extension Study
    Wolf, Douglas C.
    Cross, Raymond K.
    Ritter, Timothy E.
    Stallmach, Andreas
    Hindryckx, Pieter
    Chang, Shannon
    Tharmarajah, Soba
    Wu, Hsiuanlin
    Osterman, Mark T.
    Jain, Anjali
    Irving, Peter M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1035 - S1035
  • [35] Correlations Between Early MRI Parameters and Long-Term Clinical Outcomes in Phase 3 and Open-Label Extension Studies of Ozanimod in Relapsing Multiple Sclerosis: Final Results From the DAYBREAK Open-label Extension Study
    Arnold, Douglas
    Freeman, Leorah
    Hartung, Hans-Peter
    Montalban, Xavier
    Cohen, Jeffrey
    Bar-Or, Amit
    Steinman, Lawrence
    DeLuca, John
    Sheffield, James
    Cheng, Chun-Yen
    Riolo, Jon
    Pachai, Chahin
    Cree, Bruce A. C.
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 1050 - 1051
  • [36] Extended induction in the True North OLE study: ozanimod efficacy in biologic-naive and biologicexperienced patients
    Dignass, A.
    Regueiro, M.
    Colombel, J. F.
    Jain, A.
    Canavan, J. B.
    Wu, H.
    Lawlor, G.
    Osterman, M. T.
    Vermeire, S.
    Rubin, D. T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : I110 - I111
  • [37] DURABILITY OF RESPONSE IN DELAYED RESPONDERS TO OZANIMOD IN PATIENTS WITH ULCERATIVE COLITIS STRATIFIED BY NUMBER OF PRIOR BIOLOGICS: 3-YEAR UPDATE FROM THE TRUE NORTH OPEN-LABEL EXTENSION STUDY
    Regueiro, Miguel D.
    D'Haens, Geert
    Cross, Raymond K.
    Malter, Lisa
    Irving, Peter M.
    Wu, Hsiuanlin
    Lama, Sonie
    Lawlor, Garrett
    Osterman, Mark T.
    Jain, Anjali
    Dignass, Axel
    GASTROENTEROLOGY, 2024, 166 (05) : S815 - S815
  • [38] PHASE 2 OPEN-LABEL EXTENSION STUDY WITH DONIDALORSEN TREATMENT IN PATIENTS WITH HEREDITARY ANGIOEDEMA
    Bordone, L.
    Riedl, M.
    Newman, K.
    Lui, C.
    Alexander, V.
    Schneider, E.
    Cohn, D.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S33 - S33
  • [39] An Open-Label Extension Study of Alendronate Treatment in Elderly Women with Osteoporosis
    R. W. Downs, Jr.
    H. G. Bone
    H. McIlwain
    M. Z. Baker
    A. J. Yates
    A. Lombardi
    D. Krupa
    R. Harning
    Calcified Tissue International, 1999, 64 : 463 - 469
  • [40] An open-label extension study of alendronate treatment in elderly women with osteoporosis
    Downs, RW
    Bone, HG
    McIlwain, H
    Baker, MZ
    Yates, AJ
    Lombardi, A
    Krupa, D
    Harning, R
    CALCIFIED TISSUE INTERNATIONAL, 1999, 64 (06) : 463 - 469
12345